Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Vitamin D-Binding Protein Antikörper (Internal Region)

Der Ziege Polyklonal Anti-Vitamin D-Binding Protein-Antikörper wurde für WB und ELISA validiert. Er ist geeignet, Vitamin D-Binding Protein in Proben von Human zu detektieren. Es ist 1 Publikation verfügbar.
Produktnummer ABIN263165

Kurzübersicht für Vitamin D-Binding Protein Antikörper (Internal Region) (ABIN263165)

Target

Alle Vitamin D-Binding Protein (GC) Antikörper anzeigen
Vitamin D-Binding Protein (GC)

Reaktivität

  • 74
  • 21
  • 21
  • 6
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
Human

Wirt

  • 82
  • 19
  • 1
  • 1
Ziege

Klonalität

  • 78
  • 25
Polyklonal

Konjugat

  • 64
  • 17
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser Vitamin D-Binding Protein Antikörper ist unkonjugiert

Applikation

  • 75
  • 46
  • 32
  • 23
  • 19
  • 8
  • 8
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA

Güteklasse

Verified
  • Bindungsspezifität

    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region

    Verwendungszweck

    Vitamin D-binding protein / GC

    Sequenz

    CDNLSTKNSK FED

    Homologie

    Human

    Aufreinigung

    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

    Immunogen

    Peptide with sequence CDNLSTKNSKFED, from the internal region of the protein sequence according to NP_000574.2.

    Isotyp

    IgG
  • Applikationshinweise

    DS WB Results: Approx 56 kDa band observed in Human Lung lysates (calculated MW of 52.9 kDa according to NP_000574.2). The observed molecular weight corresponds to earlier findings in literature with different antibodies (DiMartino and Kew, J Immunol. 1999 Aug 15,163(4):2135-42, PMID: 10438954). Recommended concentration: 0.1-0.3 μg/mL.

    Peptide ELISA: antibody detection limit dilution 1:2000.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.5 mg/mL

    Buffer

    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Minimize freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Vicente-Vicente, Ferreira, González-Buitrago, López-Hernández, López-Novoa, Morales: "Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats." in: Toxicology, Vol. 304, pp. 83-91, (2013) (PubMed).

  • Target

    Vitamin D-Binding Protein (GC)

    Andere Bezeichnung

    Vitamin D-binding protein / GC

    Hintergrund

    GC, vitamin D-binding protein, group-specific component (vitamin D binding protein), DBP, DBP/GC, VDBG, VDBP, vitamin D binding protein, vitamin D-binding alpha-globulin, vitamin D-binding protein/group specific component

    Gen-ID

    2638

    NCBI Accession

    NP_000574

    Pathways

    Metabolism of Steroid Hormones and Vitamin D, Monocarboxylic Acid Catabolic Process
Sie sind hier:
Chat with us!